logo-loader
HealthCannabis

Eden Pharma hits new high with fourth round of funding

The business started to sell CBD and hemp-based products on Amazon released in August and claims they are some of the “fastest-selling” in the UK

Medical Marijuana plants
It plans to open a laboratory in London this month, while acreage to grow plants in the Caribbean region will become fully operational in December

Medicinal marijuana business Eden Pharma Ltd has launched its fourth round of funding in just four months. 

The firm, which only started trading in the second quarter of this year, will sell 250,000 shares at 498p each starting on 10 January 2020.

The first two rounds of funding, for £150,000 and £850,000 respectively, were oversubscribed by 150%, while the third opened on 2 September and was filled by one single application.

Eden expects this third offering, of 200,000 shares at 240p each, to be oversubscribed as well.

The Enterprise Investment Scheme (EIS) backed business started to sell CBD and hemp-based products on Amazon in August and claims they are some of the “fastest-selling” in the UK.

It plans to open a laboratory in London this month, while acreage to grow plants in the Caribbean region will become fully operational in December.

Talks are also underway to acquire land in Cyprus, Canada and the US.

"Eden Pharma has recorded one of (if not the) fastest private equity share placement of any UK medical marijuana company in 2019,” said chief executive Martin Booth. 

“We have positioned ourselves as a truly unique marijuana company (a harvester, transporter, dispenser and researcher of marijuana), whilst also operating a retail arm of the business.”

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks quiet into the weekend after milestone week in...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada fell 1.6% to 139.34 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.5% to C$10.77, while the OTCQX Cannabis Index sank 1.5% to...

9 hours, 47 minutes ago

2 min read